Florida Cancer Specialists & Research Institute Clinical Summit Advances Strategic Priorities, Research Innovation & Excellence in Patient Care

FORT MYERS, Fla., Oct. 15, 2026 /PRNewswire/ -- Reaffirming its leadership in community oncology and commitment to expanding access to world-class cancer care, Florida Cancer Specialists & Research Institute, LLC (FCS) this week will welcome physicians, clinical practice providers and executive leaders from across its statewide network to the annual Clinical Summit.

"The FCS Clinical Summit brings our clinical experts and leadership teams together to strengthen relationships, align around key strategic priorities and share innovations that are expanding treatment options and improving cancer care and outcomes for patients worldwide," said David Wenk, MD, FCS assistant managing physician.

Over three days, attendees will examine FCS's strategic priorities in clinical performance, operational excellence and patient outcomes. Key discussions will center on the future of cellular therapy, evolving payer and value-based care strategies and continued growth of the FCS clinical research program. The agenda will also highlight advances in cancer research that are transforming outcomes and efforts to expand early- and late-phase clinical trials, increasing patient access to innovative therapies.

"Through discussions on best practices and advances driven by our clinical research program, we reinforce our collective commitment to delivering world-class care close to home," Dr. Wenk said.

Keynote speaker Billy Beane, senior adviser to Oakland Athletics owner and the central figure in the movie Moneyball, will translate his experiences into insights aimed at achieving better outcomes through data-driven decision-making, uncovering untapped opportunities and building resilient, high performing teams.

FCS CEO Ryan Ciarrocchi noted, "Annually, the Clinical Summit provides a unique opportunity to come together as colleagues, gain fresh perspectives, celebrate our successes and continue to be inspired by what's possible together as we shape the future of cancer care."

More than 250 physicians and 280 nurse practitioners and physician assistants provide care to patients with all forms of cancer and blood disorders at nearly 100 FCS locations across Florida.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. Through its robust clinical research program with Sarah Cannon Research Institute (SCRI) and a suite of independent site management programs, with advanced clinical trial matching technology, FCS offers patients innovative therapies close to home. Each year, FCS conducts more than 180 active clinical trials that directly elevate patient care and accelerate progress in oncology. Many of the cancer drugs approved by the FDA in the U.S over the past decade were accessible to patients at FCS through clinical trial participation before receiving approval.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

SOURCE Florida Cancer Specialists & Research Institute